Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Philip Hipskind
Inhibition of Sphingosine Phosphate Receptor 1 Signaling Enhances the Efficacy of VEGF Receptor Inhibition
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Inhibition of Estrogen Receptor Signaling
Breast Cancer Online
Activation Mechanisms of the First Sphingosine-1-Phosphate Receptor
Protein Science
Biochemistry
Medicine
Molecular Biology
Sphingosine 1-Phosphate Receptor 1 (S1PR1; S1P1; EDG1)
Science-Business eXchange
Sphingosine 1-Phosphate (S1p)/S1p Receptor 1 Signaling Regulates Receptor Activator of NF-κB Ligand (RANKL) Expression in Rheumatoid Arthritis
Biochemical and Biophysical Research Communications
Biochemistry
Cell Biology
Molecular Biology
Biophysics
Sphingosine-1–phosphate Receptor 2 (S1PR2; S1P2; EDG5)
Science-Business eXchange
Sphingosine 1-Phosphate Receptor 2 (S1PR2; S1P2; EDG5)
Science-Business eXchange
Sphingosine-1-Phosphate Receptor 1 Reporter Mice Reveal Receptor Activation Sites in Vivo
Journal of Clinical Investigation
Medicine
Sphingosine Kinase 1 Mediates Head & Neck Squamous Cell Carcinoma Invasion Through Sphingosine 1-Phosphate Receptor 1
Cancer Cell International
Cancer Research
Oncology
Genetics
FTY720 (Fingolimod) Efficacy in an Animal Model of Multiple Sclerosis Requires Astrocyte Sphingosine 1-Phosphate Receptor 1 (S1P1) Modulation
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary